A detailed history of Wells Fargo & Company transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 20,077 shares of CUE stock, worth $20,077. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,077
Previous 20,683 2.93%
Holding current value
$20,077
Previous $25,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.45 - $1.08 $272 - $654
-606 Reduced 2.93%
20,077 $15,000
Q2 2024

Aug 13, 2024

SELL
$1.24 - $2.18 $12,654 - $22,246
-10,205 Reduced 33.04%
20,683 $25,000
Q1 2024

May 10, 2024

BUY
$1.77 - $3.09 $2,594 - $4,529
1,466 Added 4.98%
30,888 $58,000
Q4 2023

Feb 09, 2024

SELL
$1.72 - $3.1 $83,870 - $151,162
-48,762 Reduced 62.37%
29,422 $77,000
Q3 2023

Nov 13, 2023

BUY
$2.23 - $4.69 $19,231 - $40,446
8,624 Added 12.4%
78,184 $179,000
Q2 2023

Aug 15, 2023

BUY
$3.11 - $4.91 $56,707 - $89,528
18,234 Added 35.53%
69,560 $253,000
Q1 2023

May 12, 2023

BUY
$2.41 - $3.74 $7,724 - $11,986
3,205 Added 6.66%
51,326 $183,000
Q4 2022

Feb 13, 2023

BUY
$2.39 - $3.95 $67,185 - $111,038
28,111 Added 140.48%
48,121 $137,000
Q3 2022

Nov 14, 2022

BUY
$2.23 - $3.37 $44 - $67
20 Added 0.1%
20,010 $45,000
Q2 2022

Aug 12, 2022

BUY
$2.49 - $5.92 $28,109 - $66,830
11,289 Added 129.74%
19,990 $50,000
Q1 2022

May 16, 2022

SELL
$4.41 - $12.28 $39,451 - $109,856
-8,946 Reduced 50.69%
8,701 $43,000
Q4 2021

Feb 14, 2022

BUY
$10.86 - $17.85 $180,786 - $297,148
16,647 Added 1664.7%
17,647 $200,000
Q2 2021

Aug 16, 2021

SELL
$10.9 - $14.53 $69,116 - $92,134
-6,341 Reduced 86.38%
1,000 $12,000
Q1 2021

May 13, 2021

SELL
$11.2 - $16.09 $507,091 - $728,490
-45,276 Reduced 86.05%
7,341 $89,000
Q4 2020

Feb 09, 2021

SELL
$11.12 - $16.4 $1,823 - $2,689
-164 Reduced 0.31%
52,617 $658,000
Q3 2020

Nov 05, 2020

SELL
$15.05 - $23.54 $44,909 - $70,243
-2,984 Reduced 5.35%
52,781 $795,000
Q2 2020

Aug 13, 2020

BUY
$12.7 - $30.73 $227,368 - $550,159
17,903 Added 47.28%
55,765 $1.37 Million
Q1 2020

May 14, 2020

BUY
$9.85 - $22.27 $372,940 - $843,186
37,862 New
37,862 $537,000

Others Institutions Holding CUE

About Cue Biopharma, Inc.


  • Ticker CUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,381,700
  • Market Cap $35.4M
  • Description
  • Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...
More about CUE
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.